tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Omeros Corp (OMER)
NASDAQ:OMER
US Market
OMER
Omeros
RESEARCH TOOLSreports
Advertisement

Omeros (OMER) Stock News & Sentiment

Compare
737 Followers
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
3d ago
MS
BAC
Omeros Signs Major Deal with Novo Nordisk
Premium
Company Announcements
Omeros Signs Major Deal with Novo Nordisk
3d ago
8K
OMER
Omeros Corporation Completes Promising Phase 2 Study on OMS906 for PNH
Premium
Company Announcements
Omeros Corporation Completes Promising Phase 2 Study on OMS906 for PNH
17d ago
OMER
Promising Clinical Data and Unique Mechanism of Narsoplimab Justify Buy Rating
Premium
Ratings
Promising Clinical Data and Unique Mechanism of Narsoplimab Justify Buy Rating
2M ago
OMER
Omeros Corporation’s Positive Earnings Call Highlights Progress
Premium
Company Announcements
Omeros Corporation’s Positive Earnings Call Highlights Progress
2M ago
OMER
Omeros’s Strategic Advancements with Narsoplimab: A Buy Rating Amidst Promising FDA and EMA Reviews
Premium
Ratings
Omeros’s Strategic Advancements with Narsoplimab: A Buy Rating Amidst Promising FDA and EMA Reviews
2M ago
OMER
Omeros Corporation Reports Q2 2025 Financial Results
Premium
Company Announcements
Omeros Corporation Reports Q2 2025 Financial Results
2M ago
OMER
More OMER News >

OMER News on the Web

NVO, OMER Ink $2.1B Zaltenibart Deal to Bolster Rare Disease Portfolio
Zacks
Bullish
Why Omeros Corporation’s (OMER) Stock Is Down 12.57%
AAII
Neutral
Needham Sticks to Its Hold Rating for Omeros (OMER)
TipRanks News
Neutral
Omeros Stock Soars 149% After $2.1 Billion Deal With Novo Nordisk
rttnews
Neutral
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
TipRanks News
Neutral
Omeros Secures Up to $2.1 Billion in Novo Nordisk Deal for MASP-3 Inhibitor Zaltenibart—A Major Boost for Rare Disease Therapies
Market Chameleon
Neutral
Novo Nordisk Secures Global Rights to Omeros’ MASP-3 Inhibitor Zaltenibart—$2.1B Deal Sets Up Major Milestone for Rare Disease Treatment
Market Chameleon
Neutral
Why Omeros Corporation’s (OMER) Stock Is Up 137.07%
AAII
Neutral

News Score - Last 7 Days

Neutral
OMER
Sector Average
Media Buzz
This Week8 articles
Weekly Average2.5 articles
News Sentiment
This Week100%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OMER’s Media Buzz Sentiment?
8 articles about OMER were published this week. In an average week, 2.5 articles are published.
    What is OMER’s weekly average amount of articles?
    In an average week, 2.5 articles about OMER are published.
      What is OMER’s News Sentiment?
      100% of articles about OMER were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        IXIIXICO plc
        ALNYAlnylam Pharma
        TDOCTeladoc
        JNJJohnson & Johnson
        BCRXBioCryst
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing